Journals / Van Tıp Dergisi / 2021 / Cilt: 28 - Sayı: 3

Are Biochemical Markers Important in Predicting Intensive Care Unit Admission and Mortality in COVID-19 Patients?

COVİD-19 Hastalarında Yoğun Bakım Ünitesine Kabul ve Mortaliteyi Öngörmede Biyokimyasal Belirteçlerin Önemi Var Mı?

Pages
428–433
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While there was a significant difference between the survivor and non-su rvivor patients in terms of age, neutrophil, lymphocyte, CRP, NLR, lymphocyte CRP ratio, TLR, comorbidity and hospitalization days (for all p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Many biochemical parameters have been studied in determining the clinical severity of COVID-19 disease.
📊
Key Findings & Data:In this study, the effects of NLR, TL R and lymphocyte-CRP ratio on the severity of the disease, the need for intensive care and mortality were investigated in patients diagnosed with COVID- 19.
💡
Conclusion & Impact:While there was a significant difference between the survivor and non-su rvivor patients in terms of age, neutrophil, lymphocyte, CRP, NLR, lymphocyte CRP ratio, TLR, comorbidity and hospitalization days (for all p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Many biochemical parameters have been studied in determining the clinical severity of COVID-19 disease. In this study, the effects of NLR, TL R and lymphocyte-CRP ratio on the severity of the disease, the need for intensive care and mortality were investigated in patients diagnosed with COVID- 19. Materials and Methods: COVID-19 patients who were followed up in service and intensive care units and whose diagnosis was confirmed by the laboratory at our hospital between August 1th 2020-December 1th 2020 were retrospectively screened. Demographic data and laboratory values of the patients were recorded from electronic medical records. multiple logistic regression analysis was performed in terms of mortality and need for intensive care unit treatment. Results: A thousand seven hundred fifty patients were included in the study. 151 (8.62%) patients needed follow-up in the intensive care unit. While there was a significant difference between the survivor and non-su rvivor patients in terms of age, neutrophil, lymphocyte, CRP, NLR, lymphocyte CRP ratio, TLR, comorbidity and hospitalization days (for all p

Özet

Amaç: COVID-19 hastalığının klinik şiddetini be lirlemede birçok biyokimyasal parametre çalışma konusu yapılmıştır. Bu çalışmada COVID-19 tanılı hastalarda, nötrofil-lenfosit oranı(NLO), trombosit-lenfosit oranı(TLO) ve lenfosit-C Reaktif protein oranının hastal ığın şiddeti, yoğun bakıma yatış gereksinimi ve mortalite üzerine etkileri araştırıldı. Gereç ve Yöntem: Hastanemizde 1 Ağustos 2020-1 Aralık 2020 tarihleri arasında servis ve yo ğun bakım ünitelerinde takip edilmiş ve laboratuvar ile tanısı onaylanmış COVID-19 hastaları retrospektif olarak tarandı. Elektronik medikal kayıtlardan hastaların demografik verileri ve laboratuvar de ğerleri kayıt edildi. Mortalite ve yo ğun bak ım ünitesi yat ış gereksinimi açısından çoklu lojistik regresyon analizi yapıldı. Bulgular: Çalışmaya 1750 hasta dahil edildi. 151 (%8.62) hastada yoğun bakım ünitesinde takip ihtiyacı oldu. Sağ kalan ve vefat eden hastalar aras ında ya ş, nötrofil, lenfosit, C-Reaktif proteini(CRP), NLO, lenfosit CRP oranı, TLO, komorbidite ve hastane yat ış gün say ısı değişkenleri açısından anlamlı olarak fark bulundu (hepsi için p

🔖

Cite This Article

Solmaz, İ., Araç, S., Kalın, B. S., Alakuş, Ö. F., Özçaylak, S. (2022). Are Biochemical Markers Important in Predicting Intensive Care Unit Admission and Mortality in COVID-19 Patients?. Van Tıp Dergisi, Cilt: 28 - Sayı: 3, 428–433. https://ajindex.com/articles/645955

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. WHO. Coronavirus disease (COVID 19) Situation Report 202 Situation in numbers (by WHO Region). Google Scholar 2. Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate Covid-19. N Engl J Med 2020
  2. 383(18):1757-1766. 3. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID- 19) Available from: https: / / www.who.int / publications-detail / report - of - the - who - china - joint - mission - on - coronavirus - disease. 2019 - (covid-19). 4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020
  3. 395(10223):497-506. 5. Budak F, Korkmaz Ş. COVID-19 Pandemi Sürecine Yönelik Genel Bir Değerlendirme: Türkiye Örneği. Sosyal Araştırmalar ve Yönetim Dergisi 2020
  4. :62-79. 6. Lagunas-Rangel FA. Neutrophil-to- lymphocyte ratio an d lymphocyte-to-C- reactive protein ratio in patients with severe coronavirus disease 2019 (COVID- 19): A meta-analysis. J Med Virol 2020
  5. 92(10):1733-1734. 7. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020
  6. 58(7):1021-1028. 8. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020
  7. 81(1):6-12. 9. Yelgeç N, Karataş M, Karabay C, Çanga Y, Çal ık A, Şi̇mşek B, et al. The Relationship Between Acute Renal Failure After Transcatheter Aortic Valve Replacement And Preprocedural Neutrophil To Lymphocyte Ratio. Dicle Tıp Dergisi 2020
  8. 47(1):1-9. 10. Kılıç E, Rezvani̇ A, Erek Toprak A, Erman H, Kesgi̇n Ayhan S, Poyraz E, et al. Romatoid Artritte Nötrofil/ Lenfosit ve Platelet/ Lenfosit Oranlarının Değerlendirilmesi. Dicle T ıp Dergisi 2016
  9. 43(2): 241-247. 11. Akkurt Z, Türkçü F, Uçmak D, Yıldırım A, Yüksel H, Yüksel H, et al. Behçet Hastalığında Artmış Nötrofil / Lenfosit Oranı. Kirikkale Univ Tip Fak Derg 2016
  10. 16(3):4-11. 12. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020
  11. 71(15):762-768. 13. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020:ciaa270. 14. Yufei Y, Mingli L, Xuejiao L, Xuemai D, Yiming J, Qin Q, e